Related Experiment Video
Updated: Jun 16, 2026
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
Effects of chronic lymphocytic leukemia on the development and progression of malignant melanoma
Jerry D Brewer1, Leslie J Christenson, Roger H Weenig
1Department of Dermatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. brewer.jerry@mayo.edu
Background:
An association exists between chronic lymphocytic leukemia and malignant melanoma.
Objectives:
To study the clinical behavior of malignant melanoma in patients with chronic lymphocytic leukemia.
Methods:
A retrospective chart review was conducted of patients with chronic lymphocytic leukemia and malignant melanoma.
Results:
Sixty-nine patients had malignant melanoma and chronic lymphocytic leukemia. The recurrence-free and metastasis-free survival rates at 2, 5, and 10 years were 93.4% and 89.1%, 83.8% and 93.4%, and 87.4% and 82.1%, respectively. No significant difference was observed in age- and sex-adjusted mortality rates between patients with chronic lymphocytic leukemia diagnosed before malignant melanoma and those with chronic lymphocytic leukemia diagnosed after malignant melanoma.
Limitations:
Retrospective study and small patient population.
Conclusion:
Patients with malignant melanoma and chronic lymphocytic leukemia were not shown to have worse survival rates than those with stage IA, IB, and IIA disease. Further research and prospective study are needed.
More Related Videos
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:30Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...